author-photo

Philippe Picaut

Ipsen

97

Papers

529

Citations

Citation Trend

Filter By

Papers (72) Sort By

Journal Conference Others

Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.

2020 Developmental Medicine & Child Neurology
Show All
- Source
- Cite
- Save
Citations (4)
When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis

2020
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and safety of abobotulinumtoxinA for the treatment of hemiparesis in adults with lower limb spasticity previously treated with botulinum toxin: A secondary analysis of a randomized controlled trial

2020 Pm&r
Show All
- Source
- Cite
- Save
Citations (0)
Abobotulinumtoxina injections in shoulder muscles for adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.

2020 Journal of Rehabilitation Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies

2020 Frontiers in Neurology
Show All
- Source
- Cite
- Save
Citations (6)
Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients

2019 Toxins
Show All
- Source
- Cite
- Save
Citations (1)
AbobotulinumtoxinA, onabotulinumtoxinA and incobotulinumtoxinA neurotoxin content and activity: Potential implications for duration of efficacy in patients (P5.6-018)

2019 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy

2019 Developmental Neurorehabilitation
Show All
- Source
- Cite
- Save
Citations (1)
Erratum: Correction: Field, M. et al. AbobotulinumtoxinA (Dysport A® ), OnabotulinumtoxinA (Botox A® ), and IncobotulinumtoxinA (Xeomin A® ) Neurotoxin Content and Potential Implications for Duration of Response in Patients (Toxins (2018) 10 12 PII: E115)

2019
Show All
- Source
- Cite
- Save
Citations (0)
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial

2019 Aesthetic Surgery Journal
Show All
- Source
- Cite
- Save
Citations (8)